These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 27468194)
1. Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease. Szűcs D; Béres NJ; Rokonay R; Boros K; Borka K; Kiss Z; Arató A; Szabó AJ; Vannay Á; Sziksz E; Bereczki C; Veres G World J Gastroenterol; 2016 Jul; 22(26):6027-35. PubMed ID: 27468194 [TBL] [Abstract][Full Text] [Related]
2. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. Béres NJ; Szabó D; Kocsis D; Szűcs D; Kiss Z; Müller KE; Lendvai G; Kiss A; Arató A; Sziksz E; Vannay Á; Szabó AJ; Veres G Inflamm Bowel Dis; 2016 Feb; 22(2):327-35. PubMed ID: 26752469 [TBL] [Abstract][Full Text] [Related]
3. Role of microRNA-223 in the regulation of poly(ADP-ribose) polymerase in pediatric patients with Crohn's disease. Judit Béres N; Kiss Z; Müller KE; Cseh Á; Veres-Székely A; Lippai R; Benkő R; Bartha Á; Heininger S; Vannay Á; Sziksz E; Veres G; Horváth EM Scand J Gastroenterol; 2018 Sep; 53(9):1066-1073. PubMed ID: 30299179 [TBL] [Abstract][Full Text] [Related]
4. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249 [TBL] [Abstract][Full Text] [Related]
5. Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease. Guo Z; Wu R; Gong J; Zhu W; Li Y; Wang Z; Li N; Li J J Gastroenterol Hepatol; 2015 Jan; 30(1):109-16. PubMed ID: 24910152 [TBL] [Abstract][Full Text] [Related]
6. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy. Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease. Zhao Y; Ma T; Chen W; Chen Y; Li M; Ren L; Chen J; Cao R; Feng Y; Zhang H; Shi R J Crohns Colitis; 2016 Jun; 10(6):703-12. PubMed ID: 26802080 [TBL] [Abstract][Full Text] [Related]
8. Colonic epithelial miR-31 associates with the development of Crohn's phenotypes. Keith BP; Barrow JB; Toyonaga T; Kazgan N; O'Connor MH; Shah ND; Schaner MS; Wolber EA; Trad OK; Gipson GR; Pitman WA; Kanke M; Saxena SJ; Chaumont N; Sadiq TS; Koruda MJ; Cotney PA; Allbritton N; Trembath DG; Sylvester F; Furey TS; Sethupathy P; Sheikh SZ JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282822 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease. Tang WJ; Peng KY; Tang ZF; Wang YH; Xue AJ; Huang Y World J Gastroenterol; 2018 Dec; 24(46):5234-5245. PubMed ID: 30581272 [TBL] [Abstract][Full Text] [Related]
10. Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease. Lv Y; Zhen C; Liu A; Hu Y; Yang G; Xu C; Lou Y; Cheng Q; Luo Y; Yu J; Fang Y; Zhao H; Peng K; Yu Y; Lou J; Chen J; Ni Y mSystems; 2024 Sep; 9(9):e0078324. PubMed ID: 39150251 [TBL] [Abstract][Full Text] [Related]
11. Elevated miRNA Inversely Correlates with Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776 [TBL] [Abstract][Full Text] [Related]
13. Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease. Molnár K; Vannay A; Szebeni B; Bánki NF; Sziksz E; Cseh A; Győrffy H; Lakatos PL; Papp M; Arató A; Veres G World J Gastroenterol; 2012 Jul; 18(25):3254-9. PubMed ID: 22783049 [TBL] [Abstract][Full Text] [Related]
14. Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease. Beddy D; Mulsow J; Watson RW; Fitzpatrick JM; O'Connell PR Br J Surg; 2006 Oct; 93(10):1290-6. PubMed ID: 16838391 [TBL] [Abstract][Full Text] [Related]
15. RNA-seq Reveals Transcriptomic Differences in Inflamed and Noninflamed Intestinal Mucosa of Crohn's Disease Patients Compared with Normal Mucosa of Healthy Controls. Hong SN; Joung JG; Bae JS; Lee CS; Koo JS; Park SJ; Im JP; Kim YS; Kim JW; Park WY; Kim YH Inflamm Bowel Dis; 2017 Jul; 23(7):1098-1108. PubMed ID: 28613228 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transition. Zidar N; Boštjančič E; Jerala M; Kojc N; Drobne D; Štabuc B; Glavač D J Cell Mol Med; 2016 Oct; 20(10):1813-20. PubMed ID: 27113480 [TBL] [Abstract][Full Text] [Related]
17. microRNA profiles in coeliac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts. Vaira V; Roncoroni L; Barisani D; Gaudioso G; Bosari S; Bulfamante G; Doneda L; Conte D; Tomba C; Bardella MT; Ferrero S; Locatelli M; Elli L Clin Sci (Lond); 2014 Mar; 126(6):417-23. PubMed ID: 24063611 [TBL] [Abstract][Full Text] [Related]
18. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease. Cheng X; Zhang X; Su J; Zhang Y; Zhou W; Zhou J; Wang C; Liang H; Chen X; Shi R; Zen K; Zhang CY; Zhang H Sci Rep; 2015 May; 5():10397. PubMed ID: 25997679 [TBL] [Abstract][Full Text] [Related]